Healionics’ STARgraft receives US FDA Breakthrough Device designation
Healionics Corporation has today announced that its STARgraft arteriovenous graft—which it states is designed to provide a safer and more reliable means of bloodstream...
Xeltis announces US FDA Breakthrough Device Designation for aXess and first patient treated in...
Xeltis has today announced that the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has granted aXess...
Renal Interventions’ top 10 stories of October 2024
October brought with it one-year trial outcomes, technique recommendations, and meeting updates, with Venova Medical presenting one-year results from the VENOS-1 first-in-human (FIH) trial,...
Quanta dialysis system receives US FDA clearance for home haemodialysis
Quanta Dialysis Technologies has confirmed the US Food and Drug Administration (FDA) has given 510(k) clearance for the use of its Quanta dialysis system...
